361 related articles for article (PubMed ID: 34571862)
1. The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type.
Pluta R; Czuczwar SJ; Januszewski S; Jabłoński M
Cells; 2021 Aug; 10(9):. PubMed ID: 34571862
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.
Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019137
[TBL] [Abstract][Full Text] [Related]
3. Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest.
Pluta R; Czuczwar SJ
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279289
[TBL] [Abstract][Full Text] [Related]
4.
Pluta R; Czuczwar SJ
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542064
[TBL] [Abstract][Full Text] [Related]
5. Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.
Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366028
[TBL] [Abstract][Full Text] [Related]
6. Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.
Pluta R; Furmaga-Jabłońska W; Januszewski S; Czuczwar SJ
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057429
[TBL] [Abstract][Full Text] [Related]
7. Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
Pluta R; Ouyang L; Januszewski S; Li Y; Czuczwar SJ
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671097
[TBL] [Abstract][Full Text] [Related]
8. Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids.
Pluta R; Miziak B; Czuczwar SJ
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570596
[TBL] [Abstract][Full Text] [Related]
9. Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer's Disease Proteinopathy.
Pluta R; Januszewski S; Czuczwar SJ
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008731
[TBL] [Abstract][Full Text] [Related]
10. Tau Protein Dysfunction after Brain Ischemia.
Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
J Alzheimers Dis; 2018; 66(2):429-437. PubMed ID: 30282370
[TBL] [Abstract][Full Text] [Related]
11. Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
Czuczwar SJ; Kocki J; Miziak B; Bogucki J; Bogucka-Kocka A; Pluta R
J Alzheimers Dis; 2024; 98(1):151-161. PubMed ID: 38393914
[TBL] [Abstract][Full Text] [Related]
12. Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease.
Pluta R; Bogucka-Kocka A; Ułamek-Kozioł M; Bogucki J; Januszewski S; Kocki J; Czuczwar SJ
Pharmacol Rep; 2018 Oct; 70(5):881-884. PubMed ID: 30096486
[TBL] [Abstract][Full Text] [Related]
13.
Pluta R; Kocki J; Bogucki J; Bogucka-Kocka A; Czuczwar SJ
Cells; 2023 Dec; 12(23):. PubMed ID: 38067191
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.
Pluta R; Ułamek-Kozioł M; Kocki J; Bogucki J; Januszewski S; Bogucka-Kocka A; Czuczwar SJ
Mol Neurobiol; 2020 Feb; 57(2):1281-1290. PubMed ID: 31713815
[TBL] [Abstract][Full Text] [Related]
15. Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.
Pluta R; Miziak B; Czuczwar SJ
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445917
[TBL] [Abstract][Full Text] [Related]
16. Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.
Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605320
[TBL] [Abstract][Full Text] [Related]
17. Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?
Pluta R; Januszewski S; Czuczwar SJ
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743035
[TBL] [Abstract][Full Text] [Related]
18. Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.
Fujii H; Takahashi T; Mukai T; Tanaka S; Hosomi N; Maruyama H; Sakai N; Matsumoto M
J Cereb Blood Flow Metab; 2017 Jul; 37(7):2441-2457. PubMed ID: 27629097
[TBL] [Abstract][Full Text] [Related]
19. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats.
Wen Y; Yang S; Liu R; Brun-Zinkernagel AM; Koulen P; Simpkins JW
J Biol Chem; 2004 May; 279(21):22684-92. PubMed ID: 14982935
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.
Pluta R; Ułamek-Kozioł M; Czuczwar SJ
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
